{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:15:34Z","timestamp":1789143334249,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372447"],"award-info":[{"award-number":["82372447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-026-01598-4","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:34:00Z","timestamp":1789137240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SERPINE1\/PAI-1 in Skeletal Degeneration: A Proposed Context-Dependent Framework for Bone Remodeling Regulation"],"prefix":"10.1007","volume":"117","author":[{"given":"Hang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengbo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingquan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"1598_CR1","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726\u20131733","journal-title":"Osteoporos Int"},{"key":"1598_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.21037\/atm.2020.02.175","volume":"8","author":"A Wu","year":"2020","unstructured":"Wu A, March L, Zheng X, Huang J, Wang X, Zhao J, Blyth FM, Smith E, Buchbinder R, Hoy D (2020) Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017. Ann Transl Med 8:299","journal-title":"Ann Transl Med"},{"issue":"1","key":"1598_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41413-022-00226-9","volume":"10","author":"L Tong","year":"2022","unstructured":"Tong L, Yu H, Huang X, Shen J, Xiao G, Chen L, Wang H, Xing L, Chen D (2022) Current understanding of osteoarthritis pathogenesis and relevant new approaches. Bone Res 10(1):60","journal-title":"Bone Res"},{"key":"1598_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065364","volume":"24","author":"SQ Liu","year":"2023","unstructured":"Liu SQ, Pan YR, Li T, Zou M, Liu WJ, Li QQ, Wan H, Peng J, Hao L (2023) The role of regulated programmed cell death in osteoarthritis: from pathogenesis to therapy. Int J Mol Sci 24:5364","journal-title":"Int J Mol Sci"},{"key":"1598_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052721","volume":"22","author":"M Sillen","year":"2021","unstructured":"Sillen M, Declerck PJ (2021) A narrative review on plasminogen activator inhibitor-1 and its (patho)physiological role: to target or not to target? Int J Mol Sci 22:2721","journal-title":"Int J Mol Sci"},{"key":"1598_CR6","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2174\/1389450120666190715102510","volume":"20","author":"T Urano","year":"2019","unstructured":"Urano T, Suzuki Y, Iwaki T, Sano H, Honkura N, Castellino FJ (2019) Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis. Curr Drug Targets 20:1695\u20131701","journal-title":"Curr Drug Targets"},{"key":"1598_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1755-5922.2010.00171.x","volume":"28","author":"M Cesari","year":"2010","unstructured":"Cesari M, Pahor M, Incalzi RA (2010) Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther 28:72\u201391","journal-title":"Cardiovasc Ther"},{"key":"1598_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1160\/TH08-07-0427","volume":"100","author":"RD Balsara","year":"2008","unstructured":"Balsara RD, Ploplis VA (2008) Plasminogen activator inhibitor-1: the double-edged sword in apoptosis. Thromb Haemost 100:1029\u20131036","journal-title":"Thromb Haemost"},{"key":"1598_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12964-024-01910-5","volume":"22","author":"SB Shaikh","year":"2024","unstructured":"Shaikh SB, Balaya RDA, Dagamajalu S, Bhandary YP, Unwalla H, Prasad TSK, Rahman I (2024) A signaling pathway map of plasminogen activator nhibitor-1 (PAI-1\/SERPINE-1): a review of an innovative frontier in molecular aging and cellular senescence. Cell Commun Signal 22:544","journal-title":"Cell Commun Signal"},{"key":"1598_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2025.100892","volume":"49","author":"A Khoddam","year":"2025","unstructured":"Khoddam A, Miyata T, Vaughan D (2025) PAI-1 is a common driver of aging and diverse diseases. Biomed J 49:100892","journal-title":"Biomed J"},{"key":"1598_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1055\/s-0034-1387883","volume":"40","author":"M Eren","year":"2014","unstructured":"Eren M, Boe AE, Klyachko EA, Vaughan DE (2014) Role of plasminogen activator inhibitor-1 in senescence and aging. Semin Thromb Hemost 40:645\u2013651","journal-title":"Semin Thromb Hemost"},{"key":"1598_CR12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.14336\/AD.2023.0208","volume":"14","author":"CS Jiang","year":"2023","unstructured":"Jiang CS, Rana T, Jin LW, Farr SA, Morley JE, Qin H, Liu G, Liu RM (2023) Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer\u2019s Disease. Aging Dis 14:515\u2013528","journal-title":"Aging Dis"},{"issue":"11","key":"1598_CR13","doi-asserted-by":"publisher","first-page":"eaao1617","DOI":"10.1126\/sciadv.aao1617","volume":"3","author":"SS Khan","year":"2017","unstructured":"Khan SS, Shah SJ, Klyachko E, Baldridge AS, Eren M, Place AT, Aviv A, Puterman E, Lloyd-Jones DM, Heiman M, Miyata T, Gupta S, Shapiro AD, Vaughan DE (2017) A null mutation in SERPINE1 protects against biological aging in humans. Sci Adv 3(11):eaao1617","journal-title":"Sci Adv"},{"key":"1598_CR14","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.2337\/db12-1552","volume":"62","author":"Y Tamura","year":"2013","unstructured":"Tamura Y, Kawao N, Okada K, Yano M, Okumoto K, Matsuo O, Kaji H (2013) Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice. Diabetes 62:3170\u20133179","journal-title":"Diabetes"},{"key":"1598_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/2211-5463.12390","volume":"8","author":"G Jin","year":"2018","unstructured":"Jin G, Aobulikasimu A, Piao J, Aibibula Z, Koga D, Sato S, Ochi H, Tsuji K, Nakabayashi T, Miyata T, Okawa A, Asou Y (2018) A small-molecule PAI-1 inhibitor prevents bone loss by stimulating bone formation in a murine estrogen deficiency-induced osteoporosis model. FEBS Open Bio 8:523\u2013532","journal-title":"FEBS Open Bio"},{"key":"1598_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00774-024-01510-w","volume":"42","author":"K Okada","year":"2024","unstructured":"Okada K, Niwa Y, Fukuhara K, Ohira T, Mizukami Y, Kawao N, Matsuo O, Kaji H (2024) Plasminogen activator inhibitor-1 is involved in glucocorticoid-induced decreases in angiogenesis during bone repair in mice. J Bone Miner Metab 42:282\u2013289","journal-title":"J Bone Miner Metab"},{"key":"1598_CR17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.173603","volume":"9","author":"Q Wang","year":"2024","unstructured":"Wang Q, Shao G, Zhao X, Wong HH, Chin K, Zhao M, Bai A, Bloom MS, Love ZZ, Chu CR, Cheng Z, Robinson WH (2024) Dysregulated fibrinolysis and plasmin activation promote the pathogenesis of osteoarthritis. JCI Insight 9:e173603","journal-title":"JCI Insight"},{"key":"1598_CR18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12891-017-1752-5","volume":"18","author":"A Moritake","year":"2017","unstructured":"Moritake A, Kawao N, Okada K, Tatsumi K, Ishida M, Okumoto K, Matsuo O, Akagi M, Kaji H (2017) Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice. BMC Musculoskelet Disord 18:392","journal-title":"BMC Musculoskelet Disord"},{"key":"1598_CR19","doi-asserted-by":"publisher","first-page":"622473","DOI":"10.3389\/fcvm.2020.622473","volume":"7","author":"M Sillen","year":"2020","unstructured":"Sillen M, Declerck PJ (2020) Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition. Front Cardiovasc Med 7:622473","journal-title":"Front Cardiovasc Med"},{"key":"1598_CR20","doi-asserted-by":"publisher","DOI":"10.1055\/a-2698-4219","volume":"9","author":"J Wortley","year":"2025","unstructured":"Wortley J, Vu J, Soogoor N, Becerra M, Sathyamoorthy M (2025) A contemporary review of plasminogen activator inhibitor type 1: structure, function, genetic architecture, and intracellular\/extracellular roles. TH Open 9:a26984219","journal-title":"TH Open"},{"key":"1598_CR21","doi-asserted-by":"publisher","first-page":"25795","DOI":"10.1074\/jbc.M115.677567","volume":"290","author":"L Gong","year":"2015","unstructured":"Gong L, Liu M, Zeng T, Shi X, Yuan C, Andreasen PA, Huang M (2015) Crystal structure of the michaelis complex between tissue-type plasminogen activator and plasminogen activators Inhibitor-1. J Biol Chem 290:25795\u201325804","journal-title":"J Biol Chem"},{"key":"1598_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40432-w","volume":"9","author":"EM Marijanovic","year":"2019","unstructured":"Marijanovic EM, Fodor J, Riley BT, Porebski BT, Costa MGS, Kass I, Hoke DE, McGowan S, Buckle AM (2019) Reactive centre loop dynamics and serpin specificity. Sci Rep 9:3870","journal-title":"Sci Rep"},{"key":"1598_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1445294","volume":"15","author":"T Yatsenko","year":"2024","unstructured":"Yatsenko T, Rios R, Nogueira T, Salama Y, Takahashi S, Adachi E, Tabe Y, Hattori N, Osada T, Naito T, Takahashi K, Hattori K, Heissig B (2024) The influence of 4G\/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction. Front Immunol 15:1445294","journal-title":"Front Immunol"},{"key":"1598_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10555-019-09806-4","volume":"38","author":"MH Kubala","year":"2019","unstructured":"Kubala MH, DeClerck YA (2019) The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding. Cancer Metastasis Rev 38:483\u2013492","journal-title":"Cancer Metastasis Rev"},{"key":"1598_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11121378","volume":"11","author":"HY Cho","year":"2021","unstructured":"Cho HY, Park HS, Ahn EH, Ko EJ, Park HW, Kim YR, Kim JH, Lee WS, Kim NK (2021) Association of polymorphisms in plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA), and renin (REN) with recurrent pregnancy loss in Korean women. J Pers Med 11:1378","journal-title":"J Pers Med"},{"key":"1598_CR26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1159\/000516195","volume":"182","author":"TY Chen","year":"2021","unstructured":"Chen TY, Zhou M, Lin MQ, Liang ST, Yan Y, Wang SM, Fang CS, Li D, Ruan Y (2021) Research progress on the SERPINE1 protein and chronic inflammatory diseases of the upper respiratory tract: a literature review. Int Arch Allergy Immunol 182:1097\u20131102","journal-title":"Int Arch Allergy Immunol"},{"key":"1598_CR27","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1046\/j.1538-7836.2003.00279.x","volume":"1","author":"I Juhan-Vague","year":"2003","unstructured":"Juhan-Vague I, Alessi MC, Mavri A, Morange PE (2003) Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 1:1575\u20131579","journal-title":"J Thromb Haemost"},{"key":"1598_CR28","doi-asserted-by":"publisher","first-page":"653655","DOI":"10.3389\/fcvm.2021.653655","volume":"8","author":"GB Morrow","year":"2021","unstructured":"Morrow GB, Whyte CS, Mutch NJ (2021) A serpin with a finger in many PAIs: PAI-1\u2019s central function in thromboinflammation and cardiovascular disease. Front Cardiovasc Med 8:653655","journal-title":"Front Cardiovasc Med"},{"key":"1598_CR29","doi-asserted-by":"publisher","first-page":"342391","DOI":"10.1155\/2009\/342391","volume":"2009","author":"R Samarakoon","year":"2009","unstructured":"Samarakoon R, Higgins CE, Higgins SP, Higgins PJ (2009) TGF-beta1-induced expression of the poor prognosis SERPINE1\/PAI-1 gene requires EGFR signaling: a new target for Anti-EGFR therapy. J Oncol 2009:342391","journal-title":"J Oncol"},{"key":"1598_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27010086","volume":"27","author":"J Ke","year":"2026","unstructured":"Ke J, Jiang Y, Cheng Z, Zhou Y, Lu J, Xu B, Yan S, Wang J (2026) PAI-1: a key signal at the crossroads of stem cell differentiation and senescence. Int J Mol Sci 27:86","journal-title":"Int J Mol Sci"},{"key":"1598_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197066","volume":"21","author":"FA Rahman","year":"2020","unstructured":"Rahman FA, Krause MP (2020) PAI-1, the plasminogen system, and skeletal muscle. Int J Mol Sci 21:7066","journal-title":"Int J Mol Sci"},{"key":"1598_CR32","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1172\/JCI11765","volume":"106","author":"DJ Loskutoff","year":"2000","unstructured":"Loskutoff DJ, Quigley JP (2000) PAI-1, fibrosis, and the elusive provisional fibrin matrix. J Clin Invest 106:1441\u20131443","journal-title":"J Clin Invest"},{"key":"1598_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cellsig.2012.10.003","volume":"25","author":"R Samarakoon","year":"2013","unstructured":"Samarakoon R, Overstreet JM, Higgins PJ (2013) TGF-\u03b2 signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. Cell Signal 25:264\u2013268","journal-title":"Cell Signal"},{"key":"1598_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.yjmcc.2007.12.006","volume":"44","author":"R Samarakoon","year":"2008","unstructured":"Samarakoon R, Higgins SP, Higgins CE, Higgins PJ (2008) TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)\/EGFR(Y845) and Rho\/ROCK signaling. J Mol Cell Cardiol 44:527\u2013538","journal-title":"J Mol Cell Cardiol"},{"key":"1598_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1377-8","volume":"10","author":"C Deroyer","year":"2019","unstructured":"Deroyer C, Charlier E, Neuville S, Malaise O, Gillet P, Kurth W, Chariot A, Malaise M, de Seny D (2019) CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes. Cell Death Dis 10:103","journal-title":"Cell Death Dis"},{"key":"1598_CR36","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/ATVBAHA.117.309451","volume":"37","author":"DE Vaughan","year":"2017","unstructured":"Vaughan DE, Rai R, Khan SS, Eren M, Ghosh AK (2017) Plasminogen activator inhibitor-1 is a marker and a mediator of senescence. Arterioscler Thromb Vasc Biol 37:1446\u20131452","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1598_CR37","doi-asserted-by":"publisher","first-page":"645593","DOI":"10.3389\/fcell.2021.645593","volume":"9","author":"R Kumari","year":"2021","unstructured":"Kumari R, Jat P (2021) Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol 9:645593","journal-title":"Front Cell Dev Biol"},{"key":"1598_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13071727","volume":"13","author":"J Liu","year":"2025","unstructured":"Liu J, Yu H, Xu Y (2025) Targeting cellular senescence: pathophysiology in multisystem age-related diseases. Biomedicines 13:1727","journal-title":"Biomedicines"},{"key":"1598_CR39","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/acel.12643","volume":"16","author":"C Jiang","year":"2017","unstructured":"Jiang C, Liu G, Luckhardt T, Antony V, Zhou Y, Carter AB, Thannickal VJ, Liu RM (2017) Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease. Aging Cell 16:1114\u20131124","journal-title":"Aging Cell"},{"key":"1598_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells12152008","volume":"12","author":"T Rana","year":"2023","unstructured":"Rana T, Jiang C, Banerjee S, Yi N, Zmijewski JW, Liu G, Liu RM (2023) PAI-1 regulation of p53 expression and senescence in type II alveolar epithelial cells. Cells 12:2008","journal-title":"Cells"},{"key":"1598_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33297-7","volume":"13","author":"A Aobulikasimu","year":"2023","unstructured":"Aobulikasimu A, Liu T, Piao J, Sato S, Ochi H, Okawa A, Tsuji K, Asou Y (2023) SIRT6-PAI-1 axis is a promising therapeutic target in aging-related bone metabolic disruption. Sci Rep 13:7991","journal-title":"Sci Rep"},{"key":"1598_CR42","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/iub.2049","volume":"71","author":"J Bi","year":"2019","unstructured":"Bi J, Cai W, Ma T, Deng A, Ma P, Han Y, Lou C, Wu L (2019) Protective effect of vildagliptin on TNF-\u03b1-induced chondrocyte senescence. IUBMB Life 71:978\u2013985","journal-title":"IUBMB Life"},{"key":"1598_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-022-03463-0","volume":"18","author":"R Chen","year":"2023","unstructured":"Chen R, Zhang X, Zhu X, Wang C, Xu W (2023) Myricetin alleviated hydrogen peroxide-induced cellular senescence of nucleus pulposus cell through regulating SERPINE1. J Orthop Surg Res 18:143","journal-title":"J Orthop Surg Res"},{"key":"1598_CR44","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","volume":"342","author":"HP Kohler","year":"2000","unstructured":"Kohler HP, Grant PJ (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342:1792\u20131801","journal-title":"N Engl J Med"},{"key":"1598_CR45","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.117.028145","volume":"136","author":"P Flevaris","year":"2017","unstructured":"Flevaris P, Khan SS, Eren M, Schuldt AJT, Shah SJ, Lee DC, Gupta S, Shapiro AD, Burridge PW, Ghosh AK, Vaughan DE (2017) Plasminogen activator inhibitor type I controls cardiomyocyte transforming growth factor-\u03b2 and cardiac fibrosis. Circulation 136:664\u2013679","journal-title":"Circulation"},{"key":"1598_CR46","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1359\/jbmr.2000.15.8.1510","volume":"15","author":"E Daci","year":"2000","unstructured":"Daci E, Verstuyf A, Moermans K, Bouillon R, Carmeliet G (2000) Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency. J Bone Miner Res 15:1510\u20131516","journal-title":"J Bone Miner Res"},{"key":"1598_CR47","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bone.2007.08.020","volume":"41","author":"SM Nordstrom","year":"2007","unstructured":"Nordstrom SM, Carleton SM, Carson WL, Eren M, Phillips CL, Vaughan DE (2007) Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization. Bone 41:995\u20131004","journal-title":"Bone"},{"key":"1598_CR48","doi-asserted-by":"publisher","first-page":"9687","DOI":"10.1002\/jcp.27655","volume":"234","author":"Y Takafuji","year":"2019","unstructured":"Takafuji Y, Tatsumi K, Ishida M, Kawao N, Okada K, Matsuo O, Kaji H (2019) Plasminogen activator inhibitor-1 deficiency suppresses osteoblastic differentiation of mesenchymal stem cells in mice. J Cell Physiol 234:9687\u20139697","journal-title":"J Cell Physiol"},{"key":"1598_CR49","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/jbmr.5650110814","volume":"11","author":"G Leloup","year":"1996","unstructured":"Leloup G, Lemoine P, Carmeliet P, Vaes G (1996) Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor. J Bone Miner Res 11:1146\u20131157","journal-title":"J Bone Miner Res"},{"key":"1598_CR50","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1359\/jbmr.1999.14.6.946","volume":"14","author":"E Daci","year":"1999","unstructured":"Daci E, Udagawa N, Martin TJ, Bouillon R, Carmeliet G (1999) The role of the plasminogen system in bone resorption in vitro. J Bone Miner Res 14:946\u2013952","journal-title":"J Bone Miner Res"},{"key":"1598_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T S\u00f6zen","year":"2017","unstructured":"S\u00f6zen T, \u00d6z\u0131\u015f\u0131k L, Ba\u015faran N (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46\u201356","journal-title":"Eur J Rheumatol"},{"key":"1598_CR52","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2147\/TCRM.S138000","volume":"14","author":"F Pouresmaeili","year":"2018","unstructured":"Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM (2018) A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag 14:2029\u20132049","journal-title":"Ther Clin Risk Manag"},{"key":"1598_CR53","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.clinthera.2015.06.006","volume":"37","author":"MT Drake","year":"2015","unstructured":"Drake MT, Clarke BL, Lewiecki EM (2015) The pathophysiology and treatment of osteoporosis. Clin Ther 37:1837\u20131850","journal-title":"Clin Ther"},{"key":"1598_CR54","first-page":"3905","volume":"11","author":"S Murano","year":"1991","unstructured":"Murano S, Thweatt R, Shmookler Reis RJ, Jones RA, Moerman EJ, Goldstein S (1991) Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence. Mol Cell Biol 11:3905\u20133914","journal-title":"Mol Cell Biol"},{"key":"1598_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092686","volume":"9","author":"L Mao","year":"2014","unstructured":"Mao L, Kawao N, Tamura Y, Okumoto K, Okada K, Yano M, Matsuo O, Kaji H (2014) Plasminogen activator inhibitor-1 is involved in impaired bone repair associated with diabetes in female mice. PLoS ONE 9:e92686","journal-title":"PLoS ONE"},{"key":"1598_CR56","doi-asserted-by":"publisher","first-page":"17128","DOI":"10.1016\/S0021-9258(18)41903-5","volume":"267","author":"CF Reilly","year":"1992","unstructured":"Reilly CF, Hutzelmann JE (1992) Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution. J Biol Chem 267:17128\u201317135","journal-title":"J Biol Chem"},{"key":"1598_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/biom9080341","volume":"9","author":"R Samarakoon","year":"2019","unstructured":"Samarakoon R, Higgins SP, Higgins CE, Higgins PJ (2019) The TGF-\u03b21\/p53\/PAI-1 signaling axis in vascular senescence: role of caveolin-1. Biomolecules 9:341","journal-title":"Biomolecules"},{"key":"1598_CR58","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.2741\/2285","volume":"12","author":"Y Aso","year":"2007","unstructured":"Aso Y (2007) Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. Front Biosci 12:2957\u20132966","journal-title":"Front Biosci"},{"key":"1598_CR59","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","volume":"122","author":"F Samad","year":"2013","unstructured":"Samad F, Ruf W (2013) Inflammation, obesity, and thrombosis. Blood 122:3415\u20133422","journal-title":"Blood"},{"key":"1598_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060516","volume":"13","author":"Y Kanno","year":"2024","unstructured":"Kanno Y (2024) The roles of fibrinolytic factors in bone destruction caused by inflammation. Cells 13:516","journal-title":"Cells"},{"key":"1598_CR61","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/ijos.2015.57","volume":"8","author":"D-M Zhang","year":"2016","unstructured":"Zhang D-M, Cui D-X, Xu R-S, Zhou Y-C, Zheng L-W, Liu P, Zhou X-D (2016) Phenotypic research on senile osteoporosis caused by SIRT6 deficiency. Int J Oral Sci 8:84\u201392","journal-title":"Int J Oral Sci"},{"key":"1598_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122062","volume":"17","author":"JO Kim","year":"2016","unstructured":"Kim JO, Han SH, Lee YH, Ahn TK, Lim JJ, Chung YS, Shin DE, Lee WS, Han IB, Kim NK (2016) Association of plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms with osteoporotic vertebral compression fractures (OVCFs) in postmenopausal women. Int J Mol Sci 17:2062","journal-title":"Int J Mol Sci"},{"key":"1598_CR63","doi-asserted-by":"publisher","first-page":"e70290","DOI":"10.1002\/mco2.70290","volume":"6","author":"W Liu","year":"2020","unstructured":"Liu W, Guo NY, Wang JQ, Xu BB (2020) Osteoarthritis: mechanisms and therapeutic advances. MedComm 6:e70290","journal-title":"MedComm"},{"key":"1598_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010040","volume":"9","author":"S P\u00e9rez-Garc\u00eda","year":"2019","unstructured":"P\u00e9rez-Garc\u00eda S, Carri\u00f3n M, Guti\u00e9rrez-Ca\u00f1as I, Villanueva-Romero R, Castro D, Mart\u00ednez C, Gonz\u00e1lez-\u00c1lvaro I, Blanco FJ, Juarranz Y, Gomariz RP (2019) Profile of matrix-remodeling proteinases in osteoarthritis: impact of fibronectin. Cells 9:40","journal-title":"Cells"},{"key":"1598_CR65","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.2741\/3032","volume":"13","author":"M Del Rosso","year":"2008","unstructured":"Del Rosso M, Fibbi G, Pucci M, Margheri F, Serrati S (2008) The plasminogen activation system in inflammation. Front Biosci 13:4667\u20134686","journal-title":"Front Biosci"},{"key":"1598_CR66","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1186\/ar606","volume":"5","author":"T Jin","year":"2003","unstructured":"Jin T, Tarkowski A, Carmeliet P, Bokarewa M (2003) Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis. Arthritis Res Ther 5:R9-r17","journal-title":"Arthritis Res Ther"},{"key":"1598_CR67","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0002-9440(10)62299-7","volume":"166","author":"J Li","year":"2005","unstructured":"Li J, Ny A, Leonardsson G, Nandakumar KS, Holmdahl R, Ny T (2005) The plasminogen activator\/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis. Am J Pathol 166:783\u2013792","journal-title":"Am J Pathol"},{"key":"1598_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12031-013-0189-z","volume":"52","author":"S P\u00e9rez-Garc\u00eda","year":"2014","unstructured":"P\u00e9rez-Garc\u00eda S, Carri\u00f3n M, Jimeno R, Ortiz AM, Gonz\u00e1lez-\u00c1lvaro I, Fern\u00e1ndez J, Gomariz RP, Juarranz Y (2014) Urokinase plasminogen activator system in synovial fibroblasts from osteoarthritis patients: modulation by inflammatory mediators and neuropeptides. J Mol Neurosci 52:18\u201327","journal-title":"J Mol Neurosci"},{"key":"1598_CR69","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.18632\/aging.204881","volume":"15","author":"M Georget","year":"2023","unstructured":"Georget M, Defois A, Guiho R, Bon N, Allain S, Boyer C, Halgand B, Waast D, Grimandi G, Fouasson-Chailloux A, Guicheux J, Vinatier C (2023) Development of a DNA damage-induced senescence model in osteoarthritic chondrocytes. Aging (Albany NY) 15:8576\u20138593","journal-title":"Aging (Albany NY)"},{"key":"1598_CR70","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/BF02252318","volume":"45","author":"J Oleksyszyn","year":"1996","unstructured":"Oleksyszyn J, Augustine AJ (1996) Plasminogen modulation of IL-1-stimulated degradation in bovine and human articular cartilage explants. The role of the endogenous inhibitors: PAI-1, alpha 2-antiplasmin, alpha 1-PI, alpha 2-macroglobulin and TIMP. Inflamm Res 45:464\u2013472","journal-title":"Inflamm Res"},{"key":"1598_CR71","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00296-010-1737-2","volume":"32","author":"B Bayram","year":"2012","unstructured":"Bayram B, Sayin E, Erkasap N, Onl\u00fc H, Ozkurt M, Sahin F, T\u00fcrko\u011flu Z (2012) Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G\/5G polymorphism and osteoarthritis. Rheumatol Int 32:259\u2013262","journal-title":"Rheumatol Int"},{"key":"1598_CR72","doi-asserted-by":"publisher","first-page":"100877","DOI":"10.1016\/j.mgene.2021.100877","volume":"28","author":"B Bayram","year":"2021","unstructured":"Bayram B, Owen AR, Dudakovic A, Bettencourt JW, Limberg AK, Morrey ME, Sanchez-Sotelo J, Berry DJ, Kocher JP, van Wijnen AJ, Abdel MP (2021) Elevated Expression of Plasminogen Activator Inhibitor (PAI-1\/SERPINE1) is Independent from rs1799889 Genotypes in Arthrofibrosis. Meta Gene 28:100877","journal-title":"Meta Gene"},{"key":"1598_CR73","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.thromres.2013.06.023","volume":"132","author":"XN Liang","year":"2013","unstructured":"Liang XN, Xie L, Cheng JW, Tan Z, Yao J, Liu Q, Su W, Qin X, Zhao JM (2013) Association between PAI-1 4G\/5G polymorphisms and osteonecrosis of femoral head: a meta-analysis. Thromb Res 132:158\u2013163","journal-title":"Thromb Res"},{"key":"1598_CR74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-025-00681-8","volume":"12","author":"BT Hammoor","year":"2026","unstructured":"Hammoor BT, Lai CS, Xiong GX, Elliott DM, Snyder B, Vresilovic E, Bono CM, Freedman BR (2026) Intervertebral disc degeneration. Nat Rev Dis Primers 12:5","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1598_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010208","volume":"24","author":"IL Mohd Isa","year":"2022","unstructured":"Mohd Isa IL, Teoh SL, Mohd Nor NH, Mokhtar SA (2022) Discogenic low back pain: anatomy, pathophysiology and treatments of intervertebral disc degeneration. Int J Mol Sci.","journal-title":"Int J Mol Sci"},{"key":"1598_CR76","doi-asserted-by":"publisher","first-page":"e2412908","DOI":"10.1002\/advs.202412908","volume":"12","author":"K Sun","year":"2025","unstructured":"Sun K, Kang Z, Yan C, Yu Y, Han L, Shi Y, Chen L, Shi J, Chen Y, Sun J (2025) Rescuing ACE2-Deficiency-Mediated Nucleus Pulposus Senescence and Intervertebral Disc Degeneration by a Nanotopology-Enhanced RNAi System. Adv Sci (Weinh) 12:e2412908","journal-title":"Adv Sci (Weinh)"},{"key":"1598_CR77","doi-asserted-by":"publisher","first-page":"21156","DOI":"10.1021\/acsanm.5c02958","volume":"8","author":"J-W Gao","year":"2025","unstructured":"Gao J-W, Zhou Z-m, Zhou Z-m, Zhao Y, Wang X-H, Wang J, Sun R, Xu Z-y, Wang P-y, Wu X-T, Xu A-H, Wang Y-t (2025) M2 Macrophage-Derived Small Extracellular Vesicles Alleviate IVDD by Inhibiting Nucleus Pulposus Cell Fibrosis through the Akt\/FOXO1\/PAI-1 Axis. ACS Appl Nano Mater 8:21156\u201321172","journal-title":"ACS Appl Nano Mater"},{"key":"1598_CR78","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1007\/s00586-025-09035-0","volume":"34","author":"KSSV Anand","year":"2025","unstructured":"Anand KSSV, Nayagam SM, Ramachandran K, Devi N, Tangavel C, Rajasekaran S (2025) Exploring the role of Serpins as a potential molecular target in intervertebral disc degeneration. Eur Spine J 34:4592\u20134606","journal-title":"Eur Spine J"},{"key":"1598_CR79","doi-asserted-by":"publisher","first-page":"e2416149","DOI":"10.1002\/advs.202416149","volume":"12","author":"K Sun","year":"2025","unstructured":"Sun K, Shi Y, Yan C, Wang S, Han L, Li F, Xu X, Wang Y, Sun J, Kang Z, Shi J (2025) Glycolysis-derived lactate induces ACSL4 expression and lactylation to activate ferroptosis during intervertebral disc degeneration. Adv Sci (Weinh) 12:e2416149","journal-title":"Adv Sci (Weinh)"},{"key":"1598_CR80","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.joca.2024.10.003","volume":"33","author":"HD Welhaven","year":"2025","unstructured":"Welhaven HD, Welfley AH, June RK (2025) Osteoarthritis Year in Review 2024: Molecular biomarkers of osteoarthritis. Osteoarthritis Cartilage 33:67\u201387","journal-title":"Osteoarthritis Cartilage"},{"key":"1598_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199687","volume":"26","author":"SA Ozdemir","year":"2025","unstructured":"Ozdemir SA, Faizan MI, Kaur G, Shaikh SB, Ul Islam K, Rahman I (2025) Heterogeneity of cellular senescence, senotyping, and targeting by senolytics and senomorphics in lung diseases. Int J Mol Sci 26:9687","journal-title":"Int J Mol Sci"},{"key":"1598_CR82","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41413-025-00429-w","volume":"13","author":"H Wang","year":"2025","unstructured":"Wang H, Cheng P, Wang J, Lv H, Han J, Hou Z, Xu R, Chen W (2025) Advances in spatial transcriptomics and its application in the musculoskeletal system. Bone Res 13:54","journal-title":"Bone Res"},{"key":"1598_CR83","first-page":"295","volume":"50","author":"M Deng","year":"2025","unstructured":"Deng M, Tang C, Yin L, Jiang Y, Huang Y, Feng Y, Chen C (2025) Clinical and omics biomarkers in osteoarthritis diagnosis and treatment. J Orthop Transl 50:295\u2013305","journal-title":"J Orthop Transl"},{"key":"1598_CR84","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s42003-025-08316-0","volume":"8","author":"H Wang","year":"2025","unstructured":"Wang H, He X, Ma M, Dou T, Wei Y, Rux D, Qin L, Yang Y, Zhu Y, Yao L (2025) Integrating spatial and single-cell transcriptomics to characterize mouse long bone fracture healing process. Commun Biol 8:887","journal-title":"Commun Biol"},{"key":"1598_CR85","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4172\/2324-8769.1000102","volume":"1","author":"TM Simone","year":"2012","unstructured":"Simone TM, Higgins PJ (2012) Low molecular weight antagonists of plasminogen activator inhibitor-1: therapeutic potential in cardiovascular disease. Mol Med Ther 1:101","journal-title":"Mol Med Ther"},{"key":"1598_CR86","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1160\/TH08-05-0273","volume":"100","author":"R Samarakoon","year":"2008","unstructured":"Samarakoon R, Higgins PJ (2008) Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. Thromb Haemost 100:976\u2013983","journal-title":"Thromb Haemost"},{"key":"1598_CR87","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41413-023-00245-0","volume":"11","author":"T Wang","year":"2023","unstructured":"Wang T, Wang L, Zhang L, Long Y, Zhang Y, Hou Z (2023) Single-cell RNA sequencing in orthopedic research. Bone Res 11:10","journal-title":"Bone Res"},{"key":"1598_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115224","volume":"165","author":"X Hu","year":"2023","unstructured":"Hu X, Wang Z, Zhang H, Cui P, Li Y, Chen X, Kong C, Wang W, Lu S (2023) Single-cell sequencing: new insights for intervertebral disc degeneration. Biomed Pharmacother 165:115224","journal-title":"Biomed Pharmacother"},{"key":"1598_CR89","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41413-025-00442-z","volume":"13","author":"X Li","year":"2025","unstructured":"Li X, Fang L, Zhou R, Yao L, Clayton SW, Muscat S, Kamm DR, Wang C, Liu C-J, Qin L, Tower RJ, Karner CM, Guilak F, Tang SY, Loiselle AE, Meyer GA, Shen J (2025) Current cutting-edge omics techniques on musculoskeletal tissues and diseases. Bone Res 13:59","journal-title":"Bone Res"},{"key":"1598_CR90","first-page":"33","volume":"11","author":"P Lin","year":"2024","unstructured":"Lin P, Gan Y-B, He J, Lin S-E, Xu J-K, Chang L, Zhao L-M, Zhu J, Zhang L, Huang S, Hu O, Wang Y-B, Jin H-J, Li Y-Y, Yan P-L, Chen L, Jiang J-X, Liu P (2024) Advancing skeletal health and disease research with single-cell RNA sequencing. Mil Med Res 11:33","journal-title":"Mil Med Res"},{"key":"1598_CR91","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14737159.2024.2315282","volume":"24","author":"MT Hannani","year":"2024","unstructured":"Hannani MT, Thudium CS, Karsdal MA, Ladel C, Mobasheri A, Uebelhoer M, Larkin J, Bacardit J, Struglics A, Bay-Jensen AC (2024) From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers. Expert Rev Mol Diagn 24:23\u201338","journal-title":"Expert Rev Mol Diagn"},{"key":"1598_CR92","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41584-024-01126-4","volume":"20","author":"A Mobasheri","year":"2024","unstructured":"Mobasheri A, Loeser R (2024) Clinical phenotypes, molecular endotypes and theratypes in OA therapeutic development. Nat Rev Rheumatol 20:525\u2013526","journal-title":"Nat Rev Rheumatol"},{"key":"1598_CR93","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s41927-025-00557-0","volume":"9","author":"G Pattappa","year":"2025","unstructured":"Pattappa G, Karlsson NG, Steinecker-Frohnwieser B, Mobasheri A, Bernotiene E, Zaucke F, Roesch G, Uzieliene I, Meulenbelt I, Rios JL, Kazakova M, Boutet MA, Dvir-Ginzberg M, Groma V, Jenei-Lanzl Z, Henrotin Y, Li Z, N\u00fcrnberger S, Aulin C (2025) Towards stratification in osteoarthritis: a review of the scientific terminology used in published basic research. BMC Rheumatol 9:109","journal-title":"BMC Rheumatol"},{"key":"1598_CR94","volume-title":"GeneReviews\u00ae","author":"M Heiman","year":"2017","unstructured":"Heiman M, Gupta S, Lewandowska M, Shapiro AD (2017) Complete Plasminogen Activator Inhibitor 1 Deficiency. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds) GeneReviews\u00ae. University of Washington, Seattle, Seattle"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01598-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01598-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01598-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:02:35Z","timestamp":1789142555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-026-01598-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01598-4","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"6 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used generative AI-assisted tools to support language editing, grammar checking, and structural refinement of the manuscript. After using these tools, the authors carefully reviewed, revised, and verified the content as needed and take full responsibility for the content of the published article.","order":2,"name":"Ethics","label":"Declaration of Generative AI and AI-assisted Technologies in the Manuscript Preparation Process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"138"}}